Loading clinical trials...

Candesartan Versus Propranolol for Migraine Prevention | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2/3NCT00884663

Candesartan Versus Propranolol for Migraine Prevention

The main aim of the present study is to compare candesartan with propranolol for migraine prophylaxis.

Lead sponsor: Norwegian University of Science and Technology•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

RECRUITING

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

RECRUITINGPhase 3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505 · Chronic Migraine

RECRUITINGPhase 3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713 · Chronic Migraine

RECRUITINGNA

New Methods for Evaluating Preventive Migraine Treatment

NCT07071506 · Migraine, Migraine With or Without Aura, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment72

Start dateApr 2009

Last updatedDec 24, 2013

Condition

Migraine Without Aura Migraine With Aura Chronic Migraine

Locations shown

Norwegian National Headache Centre, St. Olavs University Hospital

Trondheim

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions